Nufarm Posts Strong HY26 Profit Growth and Deleveraging, Reaffirms FY26 Outlook

Why It Matters

The earnings surge and accelerated deleveraging enhance Nufarm’s financial flexibility, positioning it to invest in high‑margin seed tech and emerging platforms while delivering shareholder value.

Key Takeaways

• Underlying net profit rose 35% to A$52.1 m (≈US$34 m)
• Net debt fell 10% to A$1.23 bn (≈US$812 m), leverage 3.6×
• Cost‑savings program adds A$50 m (≈US$33 m) by FY27
• Seed Technologies EBITDA jumped to A$58 m (≈US$38 m)
• FY26 leverage target 2.0×, down from 2.7× in FY25

Pulse Analysis

Nufarm’s first‑half FY26 results underscore a rare combination of top‑line growth and disciplined cost control in the agricultural chemicals sector. Underlying net profit after tax surged 35% to A$52.1 million, while EBITDA climbed 18% to A$242.7 million, driven by a tighter product mix in crop protection and a rebound in seed technologies. The 3.7‑point lift in gross margin reflects both pricing power and operational efficiencies, signaling that the company’s performance‑improvement program is bearing fruit.

A central theme of the report is deleveraging. Net debt dropped 10% to A$1.23 billion, pulling the net‑debt‑to‑EBITDA ratio down to 3.6× and setting the stage for the FY26 target of 2.0×. The announced A$50 million (≈US$33 million) cost‑savings initiative, slated to reach full run‑rate by FY27, will be offset by modest implementation costs of A$15 million. With capital expenditure capped below A$200 million, free cash flow surged by A$193 million, reinforcing the firm’s ability to fund growth without over‑leveraging its balance sheet.

Looking ahead, Nufarm’s seed technology division is a key growth engine, posting EBITDA of A$58 million after a near‑doubling from the prior period. Emerging platforms such as omega‑3 canola and carinata are gaining commercial traction, highlighted by Japan’s deregulation of omega‑3 consumption and an extended offtake agreement with BP through 2050. These strategic moves diversify revenue streams and position Nufarm to capture premium pricing in specialty crops, making its reaffirmed FY26 outlook a compelling narrative for investors seeking exposure to resilient agribusiness fundamentals.